Acetylation at Lys174 is a toxic alteration of the soluble tau protein that occurs early in the AD pathology and promotes tau aggregation, neuronal damage and cognitive deficits (Min et al., 2010; Cohen et al., 2011). Here, MAPT is linked to Alzheimer disease.